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Abstract
Background: MicroRNAs are short RNAs (~22 nt) expressed by plants, animals and viruses that regulate gene
expression post-transcriptionally, and their importance is highlighted by distinct patterns of expression in many
physiological processes, including development, hematopoeisis, stress resistance, and disease. Our group has
characterized the microRNAs encoded by the avian herpesviruses; namely, oncogenic Marek’s disease (MD) virus
(MDV1), non-oncogenic MDV (MDV2) herpesvirus of turkeys (HVT), and infectious laryngotracheitis virus (ILTV).
Methods: MicroRNAs encoded by the avian herpesviruses were identified using next generation sequencing
technologies (454, Illumina).
Results: The microRNAs of each the avian herpesviruses have unique sequences, but the genomic locations are
similar, in that the microRNAs tend to be clustered in the rapidly evolving repeat regions of the viral genomes. For
a given viral species the microRNA sequence is highly conserved in different strains with the exception of a
virulence-associated polymorphism in the putative promoter of the MDV1 microRNAs upstream of the meq
oncogene. These microRNAs are relatively highly expressed in tumors produced by very virulent MDV1 isolates
compared to tumors produced by less virulent strains. MDV1 and HVT encode homologs of the host microRNA,
miR-221, which targets a gene important in cell cycle regulation. MDV1 encodes a microRNA (mdv1-miR-M4) that
shares a seed sequence with miR-155, a microRNA important in immune function. Mdv-miR-M4 is highly expressed
in MDV induced tumors, while miR-155 is present at very low levels.
Conclusions: MicroRNAs are highly conserved among different field strains of MDV1, and they are expressed in
lytic and latent infections and in MDV1-derived tumors. This suggests that these small molecules are very
important to the virus, and roles in immune evasion, anti-apoptosis, or proliferation are likely.
Background
Marek’s disease (MD) is a lymphoproliferative disorder
in which aggressive T-cell lymphomas develop within
two to six weeks following infection of susceptible
chickens with oncogenic MD virus (MDV1) [1]. The
molecular details of MDV1-induced transformation are
not well understood, but vaccines developed from
related, nononcogenic strains, such as MDV2 and her-
pesvirus of turkeys (HVT), protect animals from disease.
Thus, MD is unique among virally induced lymphomas
in that highly effective vaccines exist. Despite vaccina-
tion, MD continues to be a problem worldwide, and
new viruses with enhanced virulence have emerged over
the last three decades. This is explained, in part, because
vaccines prevent disease but not infection, and vacci-
nated chickens shed virulent virus into the environment.
MDV1 is immunosuppressive, and one explanation for
enhanced virulence of recently emerged strains is that
the virus has evolved to become increasingly competent
at immune system disarmament or evasion.
MDV1 is an a-herpesvirus, and infection includes
both lytic and latent stages. Productive infection is char-
acterized by the replication of viral DNA, the synthesis
of viral proteins, and ultimately the assembly of
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infectious virus is produced only from feather follicle
epithelium. A restrictive productive infection occurs in
B cells and chicken embryo fibroblasts (CEF) in culture,
and is characterized by viral replication and viral antigen
synthesis but no fully infectious virus particle produc-
tion. MDV1 assumes a latent posture in T lymphocytes,
with little expression of viral antigens. T lymphocytes
can be transformed by MDV1, and the virus in trans-
formed cells is generally considered to be latent, but
s e v e r a lv i r a lg e n e sa r et r a n s c r i b e di nt u m o r sa sw e l la s
in lymphoblastoid cell lines derived from them. This
includes meq,t h ec a n d i d a t eo n c o g e n ef o rM D V 1[ 2 ] ,a s
well as the latency associated transcripts (LATs) [3],
which map antisense to the major transcriptional activa-
tor ICP4 and do not encode a protein product. MDV2
is a related, non-oncogenic virus that infects chickens.
HVT is apathogenic and primarily infects turkeys, but
h a sb e e nu s e di nc o m b i n a t i o nw i t hM D V 2a sav e r y
effective vaccine against MDV1. ILTV is more distantly
r e l a t e dt oM D Va n dH V T ,a n dcauses a respiratory ill-
ness in chickens.
microRNAs. MicroRNAs are short RNAs (~22 nt) that
are important post-transcriptional regulators encoded by
the genomes of animals and plants [4]. Over 940 micro-
RNAs have been discovered in the human genome [5],
and genes encoding microRNAs have distinct expression
profiles during development, in specific tissues, in dis-
ease, and in response to stimuli (for a recent review, see
[6]). MicroRNAs are transcribed by RNA polymerase II
into long primary microRNA (pri-microRNA) tran-
scripts, which are capped and polyadenylated and can
fold into characteristic hairpin structures. The pri-
microRNA, which can encode either a single microRNA
or a cluster of several, is processed by a ribonuclease
III-like enzyme, Drosha, resulting in the liberation of a
60- to 70-nucleotide RNA hairpin (pre-microRNA). The
pre-microRNA is exported to the cytoplasm and further
processed into a short dsRNA molecule by a second
ribonuclease III-like enzyme, Dicer. A single strand of
this short dsRNA, the mature microRNA, is incorpo-
rated into the RNA-induced silencing complex (RISC),
which includes the endonuclease Argonaute, while the
other strand, known as the star or passenger strand, is
usually degraded. The RISC complex directs transcript
cleavage or translational repression of target genes, and
it is generally thought that the choice of mechanism
depends on the degree of complementarity between the
microRNA and its target site on an mRNA. In plants,
microRNAs show high complementarity to their target
mRNAs, and this results in endonucleolytic transcript
cleavage known as ‘slicing’ [7]. In animals, complemen-
tarity between nucleotides 2-7/8 of the microRNA
(known as the ‘seed’ sequence) and the 3’UTR of the
target mRNA appears to be crucial for directing transla-
tional repression, the predominant mechanism for
microRNA action in animals (reviewed in[8]).
Herpesviruses also encode microRNAs. Herpesviruses
have developed strategies to evade the host immune
response during both lytic replication and persistent
latent infections. Viral protein coding genes carry out
varied functions important to viral survival such as
blocking interferon responses, inhibiting apoptosis and
interfering with innate and adaptive immune responses.
The microRNAs encoded by herpesviruses are now
receiving attention as critical regulators of both viral
and host genes and are like to play key roles in viral
survival [9].
We postulated that MDV1 and other avian herpes-
viruses (MDV2, HVT and infectious laryngotracheitis
virus (ILTV) encode microRNAs; this paper reviews cur-
rent information about avian herpesvirus microRNAs
and their roles.
Methods
Deep sequencing and sequence analysis
Total RNA was purified using Trizol (Invitrogen, Carls-
bad, CA), and small RNAs were purified, and cloned,
a n ds u b m i t t e dt o4 5 4( B r a n f o r d ,C T )o rt oI l l u m i n a
(Hayward, CA) for sequencing. Sequence reads were
compared to the chicken and viral genomes, allowing
only exact matches using an in-house developed analysis
pipeline. After filtering out other known small RNAs,
candidate microRNA sequences mapping to unique loci
were tallied to determine sequencing read frequency.
Cell cultures and viruses
CEF were prepared as described previously [10,11].
MDV1, MDV2 and HVT strains were from the Univer-
sity of Delaware collection, ILTV USDA was from
ATCC via the University of Delaware collection.
RNA preparation and northern blotting
RNA was purified using Trizol, electrophoresed on acry-
lamide gels, and hybridized to
32P-labeled antisense oli-
gonucleotide probes as described previously [12].
Results and discussion
MDV1, MDV2, HVT, and ILTV encode microRNAs
Our laboratory has identified microRNAs encoded by
four avian herpesviruses, MDV1, MDV2, HVT, and
ILTV [13,14]. Like other herpesviruses, the genome of
the avian herpesviruses contains unique long (UL)a n d
unique short (US) regions that are flanked by terminal
and internal repeats (I/TRL;I / T R S). The unique regions
contain functionally conserved protein coding
sequences, while the repeats generally encode virus-spe-
cific genes. The avian herpesvirus microRNAs tend to
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ure 1). In accordance with these being virus-specific
regions, there is no conservation of sequence among any
of the microRNAs from the different viruses. We have
speculated that the viral microRNAs appeared with the
evolution of the repeat regions, suggesting that the func-
tion of the microRNAs is to provide an advantage to the
virus, and if their acquisition produced a loss-of-func-
tion, this could be complemented by sequences in the
other repeat. Gain-of-function mutations, however,
would be maintained and eventually duplicated.
In MDV1, microRNAs either flank the meq oncogene
or lie in the region encoding the LATs [13,15]. The pre-
dominant ILTV microRNAs are antisense to the ICP4
gene, which encodes an essential immediate early tran-
scriptional activator, and so ILTV microRNAs could
serve to regulate ICP4 mRNA levels [16]. It is interest-
ing that several of the HVT microRNAs appear to have
arisen from local duplications of portions of the viral
genome [14]. A striking sequence similarity between
two MDV1 microRNAs (mdv1-miR-M7, M10) suggests
that they also may have been generated by local duplica-
tion within the genome.
Viral microRNAs are highly conserved among strains
In contrast to the lack of sequence conservation among
the different avian herpesviruses, the microRNAs of the
different viral strains are highly conserved.
In MDV1, the sequence of all microRNAs was con-
served among 23 different strains representing three
pathotypes. However, one polymorphism in the putative
promoter for the meq microRNA cluster correlates with
pathogenicity, and could be responsible for the differ-
ence in expression of the meq microRNAs in tumors
from very virulent pathotypes [17] (Table 1).
Only two strains of HVT (FC126, PB1) and two
MDV2 strains (SB1 and HPRS-24) are available for
sequence comparison. In preliminary studies, no poly-
morphisms have been identified in microRNAs of
MDV2, while three polymorphisms were found in HVT
PB1 microRNAs (hvt-miR-H3-5p;12-5p;16-5p) com-
pared to the reference strain FC126. In both hvt-miR-
H12-5p and 16-5p, the polymorphism is located within
the seed sequence. Similarly, the sequence of the predo-
minant ILTV microRNAs, iltv-miR-I5 and I6, are highly
conserved; these microRNAs lie antisense to the ICP4
gene and this region is identical in the 22 strains of
ILTV included in GenBank.
Overall, the high level of conservation supports the
idea that there is selective pressure to maintain the
microRNA sequences, inferring that viral microRNAs
have important functions [18]. Despite the lack of
sequence identity among the microRNAs of the different
avian herpesviruses, there may be overlaps in function.
Typically, a microRNA binds to the 3’UTR of target
genes, with binding mediated through the ‘seed’
sequence (nt 2-7/8) of the microRNA [19]. Thus, the
same gene could be targeted at different sequences by
different microRNAs, and some of these divergent avian
herpesviral microRNAs could share targets.
Viral orthologs of host microRNAs
One of the HVT microRNAs, hvt-miR-H14-3p, is a
homologue of gga-miR-221 with 21/23 nucleotide iden-
tity, including complete conservation of the seed/family
sequence. There is sequence similarity with downstream
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Figure 1 Schematic representation of avian herpesviruses and
location of clusters of microRNAs. Terminal and internal short
and long repeats are designated TRS, IRS, TRL and TRS. The
approximate location and direction of transcription of microRNA
clusters are indicated by the arrows. Lengths of each region are not
drawn to scale.
Table 1 Relative expression levels of MDV1 microRNAs in
tumors produced by a very virulent + strain (vv+, 615K)
compared to a very virulent strain (vv, RB1B) strain
microRNA vv
+/vv
Upstream of meq
mdv1-miR-M2-5p 3.9
mdv1-miR-M2-3p 6.4
mdv1-miR-M3-5p 1.6
mdv1-miR-M4-5p 3.3
mdv1-miR-M5-3p 3.2
mdv1-miR-M12-3p 2.3
LAT region
mdv1-miR-M6-5p 0.9
mdv1-miR-M6-3p 1
mdv1-miR-M7-5p 1.1
mdv1-miR-M7-3p 0.7
mdv1-miR-M8-5p 0.9
mdv1-miR-M8-3p 0.9
Ratios were derived from average densitometry of northern blot analysis of
samples from two different chickens for each strain. Expression of viral DNA
was comparable in all samples. U6 was used as a loading control and showed
a ratio of 0.8.
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the chicken, miR-221 is very abundant in CEFs and
other tissues [12,20,21], and it is likely that expression is
similar in the turkey, which is the natural host of HVT.
Thus it is possible that this HVT homologue was cap-
tured from the host genome, either through propagation
in tissue culture or during infection and replication in
the host. MDV1 contains a microRNA (mdv1-miR-M32)
that shares a seed sequence with miR-221 {Morgan,
2008 #4818}. miR-221 targets the cyclin-dependent
kinase inhibitor 1B (p27, Kip1), a regulator of the cell
cycle G1 to S phase transition. The repression of p27 by
miR-221 is thought to play an important role in cancer
p r o g r e s s i o n[ 2 2 , 2 3 ] ,a n dc o u l dp l a yar o l ei nM D V 1 -
induced tumorigenesis {Lambeth, 2009 #5006}. Although
HVT is non-oncogenic, expression of a miR-221 ortho-
log and down-regulation of p27 could move the cell
cycle to the S phase in order to support replication of
the viral genome as well as to increase growth of
infected cells for additional viral production.
MDV1, like Kaposi’s sarcoma herpesvirus (KSHV),
encodes a microRNA that shares a seed sequence with
the host microRNA, miR-155 (kshv-miR-K11; mdv1-
miR-M4). It has been proposed that kshv-miR-K11 is a
functional ortholog of mir-155 and can regulate the
same set of host mRNAs, and this contributes to
KSHV-induced tumorigenesis [24], [25]. Because the
host response to infection must be balanced between
elimination of pathogens and limited damage to host
cells, microRNAs are ideal candidates for fine-tuning of
the rapidly changing immune response. However, the
timing and cellular location of expression are critical for
manifesting function of immunomodulatory microRNAs.
For miR-155, loss- and gain-of-function studies have
demonstrated a critical role in both immune cell devel-
opment and function. Sustained expression of miR-155
can stimulate production of granulocytes, and miR-155
over-expression can lead to neoplasia [26]. However,
miR-155 expression is complicated in that its induction
in macrophages by activation of the immune response
with lipopolysaccharides does not result in subsequent
neoplasia [27,28]. Mdv1-miR-M4 also shares some tar-
gets with mir-155, and it has been suggested that mdv1-
miR-M4 target regulation plays a role in MDV-induced
lymphomagenesis [29]. In deep sequencing studies of
MDV-induced splenic tumors, we have noted decreased
levels of miR-155 (and most microRNAs) compared to
normal spleen, resting T cells, or activated T cells
(Table 2). An overall decline in microRNA expression
has been noted in other cancers [30,31], and we
hypothesize that mdv1-miR-M4 serves to replace miR-
155 in regulating functions essential to the phenotype of
the transformed cell. In addition, as noted above, tumors
produced by more aggressive strains of MDV1 express
higher levels of mdv1-miR-M4 and other microRNAs in
this cluster (Table 1), consistent with a role in tumori-
genesis. To further elucidate the role of mdv1-miR-M4,
our laboratory has constructed arecombinant HVT that
expresses mdv-miR-M4. The recombinant virus showed
improved growth characteristics in vitro and in vivo
implying that this microRNA can confer replicative
advantages to the virus, but mdv1-miR-M4 is not tur-
morigenic in the context of HVT (unpublished results).
Thus the MDV1 ortholog of miR-155 may also be pleo-
morphic in that it facilitates viral growth by impeding
the apoptotic response to infection and also down-regu-
lates genes involved in cell cycle control.
Conclusions
The presence of microRNAs in species-specific repeat
regions of the genomes of avian herpesvirus and the
conservation among strains in a particular virus all
point to the importance of these gene regulators in
virus survival. While the functions of the viral micro-
RNAs have not been established, it is apparent that
these are ideally designed for fine-tuning the host
response to infection with viruses that replicate and also
form persistent latent infections in the host. Maintaining
cell viability and establishing a permissive environment
for unregulated synthesis of foreign DNA requires
Table 2 Sequencing frequencies of immune-related (A)
and MDV (B) microRNAs in spleen, T cells, activated T
cells (a-T), and MDV-induced splenic tumors
spleen T cells a- T cells tumor
A
gga-miR-21 15779 4441 3002 693
gga-miR-181a 2626 1507 11602 54
gga-miR-181b 727 956 9458 59
gga-miR-221 2326 2679 13295 83
gga-miR-222 324 1166 21646 72
gga-miR-146a 794 407 1165 36
gga-miR-146b 2154 1016 11865 857
gga-miR-155 499 1403 52081 29
gga-miR-92 973 1943 1799 211
B
mdv-miR-M2-5p 104
mdv-miR-M2-3p 591
mdv-miR-M3-5p 187
mdv-miR-M3-3p 50
mdv-miR-M4 6682
mdv-miR-M5 581
mdv-miR-M8-5p 345
mdv-miR-M9-5p 63
mdv-miR-M9-3p 74
mdv-miR-M12-3p 164
mdv-miR-M10-5p 12
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ing the innate immune response to infection; genes reg-
ulating these pathways are among the potential targets
for these molecules. In addition, microRNAs are emer-
ging as therpeutic targets, and understanding their roles
in viral infection has great potential for the development
of improved treatments and vaccines.
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